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Dear Editor,
We have read with great interest the paper by Vasconcelos 
and Junqueira-Júnior1 who showed that parasympathetic 
and sympathetic abnormalities occur in patients with 
chronic Chagas heart disease with no left ventricular systolic 
dysfunction. These abnormalities were observed in heart rate 
variability in the time and frequency domain. They concluded 
that “it is improbable that the marked cardiac autonomic 
dysfunction can merely be a phenomenon secondary to slight 
ventricular mechanic disturbance”. We agree.
We have demonstrated that only parasympathetic 
impairment can be observed in heart rate variability in the 
frequency domain of patients with chronic Chagas disease with 
no left ventricular systolic dysfunction2. We studied 97 patients, 
the left ventricular ejection fraction being similar in patients 
with and in those without parasympathetic impairment. 
Nonetheless, 8 (8%) of 97 patients with no electrocardiographic 
abnormality in the 12-lead electrocardiogram and no left 
ventricular systolic dysfunction at echocardiography had 
parasympathetic impairment. By contrast, sympathetic 
derangement was not observed in any of the patients with 
normal 12-lead electrocardiogram and echocardiogram. 
However, in patients with chronic Chagas heart disease, as 
observed in the study by Vasconcelos e Junqueira-Júnior, the 
proportion of sympathetic and parasympathetic dysfunction 
was similar to that found in our study. 
The fact that isolated parasympathetic impairment can 
be observed in patients with chronic Chagas disease at the 
preclinical stage may suggest a role for parasympathetic 
derangement in the pathogenesis of chronic Chagas heart 
disease. In fact, parasympathetic damage has been shown to 
induce chronic cardiomyopathy experimentally3. Therefore, 
independently of the presence of sympathetic derangement at 
the preclinical stage, as shown by Vasconcelos and Junqueira-
Júnior, the precocious parasympathetic withdrawal in the 
clinical course of Chagas disease, with the consequent increase 
in myocardial tumor necrosis factor, microvascular spasm, 
platelet aggregation, and myocardial necrosis/ischemia may play 
a causative role in the pathogenesis of Chagas heart disease.
The presence of early parasympathetic impairment can 
also account for the beneficial effects of Beta-Blocker therapy, 
experimentally4 and in patients with Chagas heart disease5. 
Thus, we think that the data provided by Vasconcelos and 
Junqueira-Júnior reinforce the notion that autonomic dysfunction 
is a primary phenomenon and should no more be seen as a 
secondary phenomenon to left ventricular systolic dysfunction.
 We suggest that a longitudinal prospective cohort study is 
mandatory to evaluate whether parasympathetic impairment, 
as detected by heart rate variability in the frequency 
domain, has a causal relationship with the appearance of 
cardiomyopathy in patients with chronic Chagas disease. 
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Response Letter
We appreciate the interest of Gerbi et al.1 in reading our article 
and thank them for their contribution with complementary 
comments based on data they recently published1. These data 
reinforce our findings that the cardiac autonomic dysfunction 
in Chagas’ disease appears to be a primary phenomenon of 
varying intensity without a strict relation of cause and effect to 
the progressive contractile disturbance2. 
In the early studies on Chagas heart disease, the 
autonomic disturbances were already considered to be 
the cause of the progressive mechanical alterations of the 
heart. Similar to the mechanism of the digestive disease, 
where the parasympathetic denervation was proved to be 
the cause of the dilatation of the esophagus and segments 
of the intestine, the parasympathetic depression associated 
with a relative increase of the sympathetic activity would 
be the determinant of the hypertrophy and dilatation of 
the heart3. This concept, however, was not corroborated by 
many subsequent studies, whose authors concluded that the 
progressive contractile alteration of the heart critically depends 
on the underlying evolutionary chronic fibrotic inflammation of 
the myocardium4,5. Therefore, the autonomic denervation and 
consequent disturbance of the cardiac neural control do not 
seem to be a direct cause of the contractile dysfunction2,6-10. 
Studies with 123I-metaiodobenzylguanidine to evaluate 
the sympathetic innervation11,12 and with 201thalium to 
evaluate the myocardial perfusion, detected an association 
between sympathetic denervation and reduced perfusion 
and segmental systolic dysfunction, in chagasics without 
evidence of cardiac involvement by conventional methods, 
suggesting that the sympathetic dysfunction could precede 
the contractile alteration. 
In a correlative functional study in chagasic subjects, 
we observed that the contractile, electrical and autonomic 
disturbances, as detected by means of echocardiography, 
conventional electrocardiogram and Valsalva maneuver, 
respectively, occurred alone or in combination in any of the 
clinical forms of the disease. Otherwise, some chagasics did 
not show evidence of any of these disturbances13. These 
findings suggest that the functional disturbances of the heart 
are not necessarily related to one another on the basis of a 
causal relationship. 
In other words, the autonomic impairment, especially 
the parasympathetic impairment, can occur alone without 
contractile alteration, in association with this alteration, or 
even be absent in the presence or absence of the mechanical 
disturbance. These alternatives of relationship between the 
two cardiac functions are observed particularly in the cardiac 
form of the disease. In the indeterminate or preclinical 
form, these alternatives are more elusive because ostensive 
manifestations of cardiac disease cannot be detected. 
Therefore, the relationship between the autonomic and 
contractile dysfunctions cannot be established in terms of 
cause and effect in one or other direction10. This concept is 
reinforced by other studies demonstrating that the cardiac 
autonomic dysfunction is a precocious and independent 
phenomenon of the contractile alteration2,7,14,15, including 
the recent work by Gerbi et al., which also detected no 
relationship between both disturbances using also heart rate 
variability analysis to characterize the autonomic status1. 
However, when both disturbances are simultaneously 
present, possibly the autonomic dysfunction can influence 
the contractile dysfunction, considering the relevant regulatory 
action of the autonomic nervous system on the myocardial 
function, but not as a relationship of causal basis. Indeed, it is 
physiologically logical to consider that the autonomic nervous 
system as a functional controller should exert an effect on the 
myocardial function as a controlled structure. It is only in the 
situation of cardiac failure that the autonomic dysfunction 
commonly and secondarily results from this syndrome, in the 
context of its pathophysiology.
Finally, despite these several convincing observations, we 
agree that well-controlled longitudinal prospective studies 
should be further carried out in order to clarify the relationship 
between the autonomic and contractile disturbances in the 
course of Chagas disease10. However, in our environment, 
conducting such studies is a very difficult task. Perhaps, the best 
way is to conduct them in a supervised endemic area of Chagas 
disease, where the subjects can be followed up for a long time.
Sincerely,
Daniel Franca Vasconcelos
Arq Bras Cardiol 2012;99(3):867-869
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